Cite

HARVARD Citation

    Yan, M. et al. (2021). Expression and Clinical Significance of miR-146a and Tumor Necrosis Factor Receptor-Associated Factor 6 (TRAF6) in Myasthenia Gravis Patient Serum. BioMed research international. p. . [Online]. 
  
Back to record